data + articles · 4 listed
newest 2019spec sheet11 rows
Allyl isothiocyanate (AITC), the pungent principle of mustard, horseradish and wasabi, is a dietary isothiocyanate and a potent agonist of the TRPA1 sensory ion channel. It induces phase II detoxification enzymes, shows cancer chemopreventive activity concentrated in the urinary bladder, and drives TRPA1-dependent sensory and vascular responses.
- Induces phase II detoxification enzymes
- Chemopreventive activity concentrated in the urinary bladder
- Activates TRPA1 with downstream sensory and analgesic-desensitizing effects
- Broad antimicrobial activity against many pathogens
- Highly bioavailable when consumed orally
- Strong mucosal, skin and eye irritant due to pungency
- High doses paradoxically promoted bladder cancer in rats
- TRPA1 activation can trigger pain, coughing and neurogenic inflammation
- Genotoxic potential at supraphysiologic concentrations
Overview
Allyl isothiocyanate is the compound responsible for the sharp burn of mustard, horseradish and wasabi. It is highly bioavailable, with nearly ninety percent of an oral dose absorbed, and it is metabolized through the mercapturic acid pathway; its metabolites concentrate strongly in the urinary bladder, making the bladder the tissue where its chemopreventive potential is most pronounced. In a syngeneic rat model of orthotopic bladder cancer, AITC combined with the COX-2 inhibitor celecoxib produced enhanced, apparently synergistic inhibition of tumor growth and muscle invasion at low doses. The pharmacology of AITC carries an important honest caveat.
Isothiocyanates that are chemopreventive at moderate exposure can behave paradoxically at high doses; AITC, benzyl isothiocyanate and phenethyl isothiocyanate all activated the oncogenic transcription factor AP-1 through c-Jun in bladder cancer cells, a mechanism consistent with reports that high-dose AITC promoted bladder carcinogenesis in rats. This dose-dependence is central to interpreting its safety. Separately, AITC is a canonical agonist of the TRPA1 channel, the so-called wasabi receptor.
Activating TRPA1 on perivascular sensory nerves, AITC dilated rat dural arteries through a calcitonin gene-related peptide-dependent and TRPA1-dependent mechanism, linking it to sensory, vascular and headache biology. TRPA1 activation underlies both its irritant pungency and its potential for analgesic desensitization of nociceptors. AITC also has broad antimicrobial activity, adding to its interest as a food-derived bioactive.
- AITC is what makes wasabi, horseradish and mustard taste hot; it activates the TRPA1 'wasabi receptor'.
- About ninety percent of an oral dose is absorbed, and it concentrates strongly in the bladder.
- At high doses in rats it can paradoxically promote bladder carcinogenesis, so more is not better.
Mechanism
AITC covalently modifies cysteine residues on target proteins. On Keap1 this activates Nrf2 and phase II detoxification enzymes; on the TRPA1 ion channel it opens the 'wasabi receptor', producing sensory activation, neurogenic via calcitonin gene-related , and, with repeated exposure, nociceptor desensitization. Its metabolites concentrate in the bladder.
receptor fingerprint
TRPA1 channelagonist
Nrf2/Keap1 pathwayactivator
Phase II detoxification enzymesinducer
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
AITC is a potent irritant to skin, eyes and mucosa, which is the basis of its pungency. Dietary exposure is considered safe, but very high doses paradoxically promoted bladder cancer in rats and can be genotoxic, so supraphysiologic intake is discouraged. TRPA1 activation can trigger pain, coughing and neurogenic inflammation.
History
AITC has long been used as a food flavoring, preservative and traditional remedy from mustard and horseradish, and became a foundational pharmacological agonist for the TRPA1 channel discovered in the 2000s.
Reputation
It is simultaneously a familiar culinary pungent, a workhorse TRPA1 research tool, and a studied but dose-sensitive chemopreventive agent, so its reputation depends heavily on dose and context.
Subjective profileweighing the evidence above
Eat the mustard and wasabi; skip the concentrated supplement. It is a potent irritant, and the same high doses that concentrate in the bladder promoted cancer there in rats, which is a strange result to gamble on for a detox-enzyme claim.
Resources
This entry is here for reference.
Research
- 2005first citedThe role of c-Jun in the AP-1 activation induced by naturally occurring isothiocyanates
- 2019most recentEffect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries
- 1.Allyl isothiocyanate as a cancer chemopreventive phytochemical
- 2.Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination
- 3.The role of c-Jun in the AP-1 activation induced by naturally occurring isothiocyanates
- 4.Effect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries
4 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Why does wasabi burn the nose?
AITC activates the TRPA1 sensory channel, the same receptor behind the pungency of mustard and horseradish.
Is AITC good or bad for cancer?
At moderate dietary exposure it is chemopreventive, but very high doses paradoxically promoted bladder cancer in rats, so dose matters.
Why is the bladder the focus of its research?
Its metabolites concentrate in the urinary bladder after absorption, giving high local exposure.
Can it help with pain?
Repeated TRPA1 activation can desensitize nociceptors, a mechanism of interest for analgesia, though acute exposure is irritating.
Is concentrated AITC safe to supplement?
It is a strong irritant with dose-dependent risks, so concentrated supplementation is not advised; culinary use is the safe context.
Adverse effects
- Strong mucosal, skin and eye irritant due to pungency
- High doses paradoxically promoted bladder cancer in rats
- TRPA1 activation can trigger pain, coughing and neurogenic inflammation
- Genotoxic potential at supraphysiologic concentrations